Global Throat Cancer Therapeutics Market 2019-2023 | 7% CAGR Projection Over the Next Five Years | Technavio
LONDON--(BUSINESS WIRE)--May 28, 2019--
The global throat cancer therapeutics market is expected to post a CAGR of close to 7% during the period 2019-2023, according to the latest market research report by Technavio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190528005695/en/
Technavio has published a new market research report on the global throat cancer therapeutics market from 2019-2023. (Graphic: Business Wire)
A key factor driving the global throat cancer therapeutics market growth is the increasing incidence of throat cancer in recent years. Throat cancer is one of the most common types of cancer in various geographic locations including Europe, Asia, and North America. In addition, the increasing incidence rate of pharyngeal cancer coupled with strong prevalence of throat cancer indications will foster the throat cancer therapeutics market. Furthermore, several pharmaceutical vendors and biotechnology companies are entering the market with innovative and novel therapeutics to cater to the huge unmet demand. In addition, increasing awareness campaigns targeting the early diagnosis of throat cancer indications, will lead to a surge in the demand for throat cancer therapeutics during the forecast period.
As per Technavio, the increase in strategic alliances will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global throat cancer therapeutics market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
Global throat cancer therapeutics market: Increasing strategic alliances
There has been a significant increase in the number of strategic alliances targeted at the development and commercialization of numerous drugs used for the treatment of pharyngeal cancer and laryngeal cancer. Market players are engaging in strategic alliances with pharmaceutical vendors to overcome the challenges associated with the regulations. These alliances also help them to increase their geographical presence. Therefore, the rapidly increasing mergers, and acquisitions among several throat cancer therapeutics market participants will foster market growth during the forecast period.
“Strategic alliances among vendors are resulting in the launch of advanced therapies and their quick approval. This will help to boost the global throat cancer therapeutics market growth during the forecast period,” says a senior research analyst at Technavio.
Global throat cancer therapeutics market: Segmentation analysis
This market research report segments the global throat cancer therapeutics market by type (pharyngeal cancer and laryngeal cancer) and geographic regions (North America, Europe, Asia, and ROW).
North America led the market in 2018, followed by Europe, Asia, and ROW respectively. The market growth in North America can be attributed to the strong prevalence of both pharyngeal cancer and laryngeal cancer in the US. The market in the region has also witnessed significant advances in diagnostic methods eventually leading to the early diagnosis of the indication.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Five Forces Analysis
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190528005695/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL PHYSICAL THERAPY
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 05/28/2019 02:21 PM/DISC: 05/28/2019 02:21 PM